Sign in Create account

SUPHA PHARMACHEM LIMITED

Services · Commercial Services & Supplies

BSE: 539561
₹0.27
▲ 0.01 (3.85%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
15/100
Weak
Valuation
—/100
Data unavailable
Momentum
39/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-79.7
Free Cash Flow
₹-1,135 Cr
as of March 31, 2025
Industry median ₹-0 Cr (372 companies)
EPS Growth (YoY)
-100.00%
as of Sept. 30, 2025
Industry median 0.00% (300 companies)
Net Profit Growth (TTM)
-106.28%
as of Sept. 30, 2025
Industry median 0.00% (325 companies)
Operating Revenue Growth (TTM)
-96.01%
as of Sept. 30, 2025
Industry median 0.00% (317 companies)
Profit Growth (YoY)
-95.83%
as of Sept. 30, 2025
Industry median 2.13% (293 companies)
Revenue Growth (YoY)
-65.80%
as of Sept. 30, 2025
Industry median 7.61% (227 companies)
Current Ratio
1.03
as of March 31, 2025
Industry median 2.48 (345 companies)
Debt to Equity
26.01
as of March 31, 2025
Industry median 0.06 (315 companies)
Interest Coverage
1.01
as of Sept. 30, 2025
Industry median 2.71 (293 companies)
Net Margin
0.86%
as of Sept. 30, 2025
Industry median 3.80% (247 companies)
Operating Margin (EBIT)
3.04%
as of Sept. 30, 2025
Industry median 6.24% (257 companies)
Operating Margin (TTM)
3.75%
as of Sept. 30, 2025
Industry median 4.63% (310 companies)
Return on Assets
-3.44%
as of March 31, 2025
Industry median 0.99% (329 companies)
Return on Capital Employed
-58.00%
as of March 31, 2025
Industry median 2.68% (300 companies)
Return on Equity
-122.31%
as of March 31, 2025
Industry median 2.11% (328 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 6 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (26.01)
  • No Return on equity is 15% or more (-122.3%)
  • Yes Net cash flow for the latest year is positive

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 4 met
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • Yes Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
3.8%
Low 0.2600 · High 0.2700
1W return
3.8%
Low 0.2500 · High 0.2700
1M return
-6.9%
Low 0.2500 · High 0.3000
52W return
-94.6%
Low 0.2500 · High 0.3400
Lifetime High ₹4368.1000 (June 30, 2023)
Lifetime Low ₹0.2500 (Sept. 25, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish1
Bearish5
5D
0.3
10D
0.3
20D
1.5
50D
18.7
100D
81.4
200D
233.8

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

0.27
Pivot
First resistance0.27
Second resistance0.28
Third resistance0.28
First support0.26
Second support0.26
Third support0.25
Day RSI16.2
Day MFI55.4
Day MACD-3.15
Day MACD signal-4.47

Beta

1M-1.14
3M-0.90
1Y-0.90
3Y0.41

Price change analysis

↓ -6.9%
Over 1 Month
LowHigh
0.250.30
↓ -94.6%
Over 3 Months
LowHigh
0.250.34
↓ -94.6%
Over 6 Months
LowHigh
0.250.34
↓ -94.6%
Over 1 Year
LowHigh
0.250.34
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (Sept. 30, 2025)
₹9 Cr
Net profit (Sept. 30, 2025)
₹0 Cr
Basic EPS (Sept. 30, 2025)
₹0.0000

Ranks #None of 315 in Commercial Services & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Dec 2025
  • Promoter1.13%
  • FII/FPI1.70%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 1.13% in Dec 2025 qtr

Historical fii holding

All shareholding details →

Deals (Bulk & Block)

All 285 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
17 Jun 2026 PRAKASH ANAND GUPTA Bulk Sell 6,510,419 0.2700 BSE
7 Apr 2026 RG TRADERS Bulk Sell 4,455,537 0.3400 BSE
30 Mar 2026 AAKASHHITESHBHAIZINZUVADIA Bulk Sell 5,685,000 0.3200 BSE
30 Mar 2026 RG TRADERS Bulk Buy 7,402,096 0.3200 BSE
18 Mar 2026 L7 HITECH PRIVATE LIMITED Bulk Sell 7,637,750 0.3900 BSE
12 Mar 2026 ISHAAN TRADEFIN LLP Bulk Buy 939,000 0.4500 BSE
12 Mar 2026 ISHAAN TRADEFIN LLP Bulk Sell 5,939,000 0.4600 BSE
12 Mar 2026 JASMITSINGHCHANDHOK Bulk Buy 7,200,000 0.4700 BSE
12 Mar 2026 SHARE INDIA SECURITIES LIMITED Bulk Sell 9,064,010 0.4600 BSE
12 Mar 2026 SHARE INDIA SECURITIES LIMITED Bulk Buy 9,366,874 0.4700 BSE

All bulk and block deals →

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from REMEDIUM LIFECARE LIMITED to SUPHA PHARMACHEM LIMITED
—NAME_CHANGEName changed from ROXY EXPORTS LIMITED to REMEDIUM LIFECARE LIMITED

All corporate actions →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (-122.3%)
  • Thin net profit margin (0.9%)
  • High financial leverage (Debt/Equity 26.01)
  • Declining revenue YoY (-65.8%)
  • Declining profit YoY (-95.8%)

Opportunities

  • RSI in oversold territory (16.2) -- a technical rebound zone

Threats

  • Down 94.6% over the past year
  • Weak interest coverage (1.0x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about SUPHA PHARMACHEM LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.